Cargando…

CRISPR Detection and Research on Screening Mutant Gene TTN of Moyamoya Disease Family Based on Whole Exome Sequencing

Moyamoya disease (MMD) has a high incidence in Asian populations and demonstrates some degree of familial clustering. Whole-exome sequencing (WES) is useful in establishing key related genes in familial genetic diseases but is time-consuming and costly. Therefore, exploring a new method will be more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yilei, Liu, Weidong, Hao, Jiheng, Jiang, Qunlong, Wang, Xingbang, Yu, Donghu, Zhang, Liyong, Dong, Zhaogang, Wang, Jiyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959584/ https://www.ncbi.nlm.nih.gov/pubmed/35355511 http://dx.doi.org/10.3389/fmolb.2022.846579

Ejemplares similares

The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas
por: Zhou, Jie, et al.
Publicado: (2022)

Dynamics of intracranial and peripheral plasma Syndecan‐1 after ischemic stroke with large vessel occlusion
por: Yin, Tengkun, et al.
Publicado: (2022)

Identification of key pathways and genes in carotid atherosclerosis through bioinformatics analysis of RNA-seq data
por: Li, Zhongchen, et al.
Publicado: (2021)

Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism
por: Liu, Zhihui, et al.
Publicado: (2022)

Comprehensive molecular analyses of an autoimmune-related gene predictive model and immune infiltrations using machine learning methods in moyamoya disease
por: Li, Shifu, et al.
Publicado: (2022)

Whole-exome sequencing identifies a potential TTN mutation in a multiplex family with inguinal hernia
por: Mihailov, E., et al.
Publicado: (2016)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Editorial: Engineering Signal Sensors Based on Reprogrammed CRISPR Technologies
por: Liu, Yuchen, et al.
Publicado: (2021)

A Small RNA Is Linking CRISPR–Cas and Zinc Transport
por: Märkle, Pascal, et al.
Publicado: (2021)

Rapid and Sensitive Diagnosis of Drug-Resistant FLT3-F691L Mutation by CRISPR Detection
por: Liu, Yin, et al.
Publicado: (2021)

The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
por: Wang, Guanghui, et al.
Publicado: (2022)

Advances and challenges in CRISPR-based real-time imaging of dynamic genome organization
por: Thuma, Jenna, et al.
Publicado: (2023)

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
por: Li, Xiaoping, et al.
Publicado: (2023)

CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo
por: Li, Chunjing, et al.
Publicado: (2021)

Glucotoxicity Activation of IL6 and IL11 and Subsequent Induction of Fibrosis May Be Involved in the Pathogenesis of Islet Dysfunction
por: Lu, Liqin, et al.
Publicado: (2021)

Knockdown of Long Non-coding RNA SNGH3 by CRISPR-dCas9 Inhibits the Progression of Bladder Cancer
por: Cao, Yu, et al.
Publicado: (2021)

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response
por: Wang, Nan, et al.
Publicado: (2022)

Knockdown of LncRNA PANDAR by CRISPR-dCas9 Decreases Proliferation and Increases Apoptosis in Oral Squamous Cell Carcinoma
por: Jia, Tingting, et al.
Publicado: (2021)

Mutant Analysis Reveals Allosteric Regulation of ClpB Disaggregase
por: Franke, Kamila B., et al.
Publicado: (2017)

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020)

The Dose-Dependent Pleiotropic Effects of the UBB(+1) Ubiquitin Mutant
por: Banasiak, Katarzyna, et al.
Publicado: (2021)

The Influence of Copy-Number of Targeted Extrachromosomal Genetic Elements on the Outcome of CRISPR-Cas Defense
por: Severinov, Konstantin, et al.
Publicado: (2016)

Bio-Layer Interferometry Analysis of the Target Binding Activity of CRISPR-Cas Effector Complexes
por: Müller-Esparza, Hanna, et al.
Publicado: (2020)

Spontaneous Embedding of DNA Mismatches Within the RNA:DNA Hybrid of CRISPR-Cas9
por: Mitchell, Brandon P., et al.
Publicado: (2020)

CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2
por: Shademan, Behrouz, et al.
Publicado: (2022)

A Qualitative Signature to Identify TERT Promoter Mutant High-Risk Tumors in Low-Grade Gliomas
por: Zheng, Weicheng, et al.
Publicado: (2022)

Editorial: Advances in wild type and mutant p53 research in cancer
por: Hernández-de la Cruz, Olga N., et al.
Publicado: (2022)

A Blue Light-Inducible CRISPR-Cas9 System for Inhibiting Progression of Melanoma Cells
por: Wu, Xia, et al.
Publicado: (2020)

Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression
por: Zheng, Hanxiong, et al.
Publicado: (2021)

From DNA-protein interactions to the genetic circuit design using CRISPR-dCas systems
por: Shaytan, A. K., et al.
Publicado: (2022)

Can CRISPR/Cas Technology Be a Felicitous Stratagem Against the COVID-19 Fiasco? Prospects and Hitches
por: Konwarh, Rocktotpal
Publicado: (2020)

CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics
por: Tiwari, Prashant Kumar, et al.
Publicado: (2023)

Structural and oxidative investigation of a recombinant high-yielding fetal hemoglobin mutant
por: Kettisen, Karin, et al.
Publicado: (2023)

Next-Generation Molecular Diagnostics Development by CRISPR/Cas Tool: Rapid Detection and Surveillance of Viral Disease Outbreaks
por: Srivastava, Sonal, et al.
Publicado: (2020)

Transcriptional Inhibition of lncRNA gadd7 by CRISPR/dCas9-KRAB Protects Spermatocyte Viability
por: Zhao, Jun, et al.
Publicado: (2021)

Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro
por: Zhuang, Chengle, et al.
Publicado: (2021)

CRISPR Cas13-Based Tools to Track and Manipulate Endogenous Telomeric Repeat-Containing RNAs in Live Cells
por: Xu, Meng, et al.
Publicado: (2022)

Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry
por: Li, Feng, et al.
Publicado: (2022)

Recent findings on the role of wild-type and mutant p53 in cancer development and therapy
por: Babamohamadi, Mehregan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4cl5t2ng6lgv6vj39u9abol6op